Dr Hina Siddiqui, DO - Medicare Hospitalist in St Charles, IL

Dr Hina Siddiqui, DO is a medicare enrolled "Hospitalist" physician in St Charles, Illinois. Her current practice location is 3755 E Main St Ste 190, St Charles, Illinois. You can reach out to her office (for appointments etc.) via phone at (630) 348-3100.

Dr Hina Siddiqui is licensed to practice in Illinois (license number 036148796) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1265895247.

Contact Information

Dr Hina Siddiqui, DO
3755 E Main St Ste 190,
St Charles, IL 60174-2463
(630) 348-3100
(630) 513-0727



Physician's Profile

Full NameDr Hina Siddiqui
GenderFemale
SpecialityHospitalist
Location3755 E Main St Ste 190, St Charles, Illinois
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1265895247
  • Provider Enumeration Date: 03/29/2016
  • Last Update Date: 10/10/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 9931566924
  • Enrollment ID: I20230607000181

Medical Identifiers

Medical identifiers for Dr Hina Siddiqui such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1265895247NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208000000XPediatrics 036.148796 (Illinois)Secondary
390200000XStudent In An Organized Health Care Education/training Program (* (Not Available))Secondary
208M00000XHospitalist 036148796 (Illinois)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Hina Siddiqui allows following entities to bill medicare on her behalf.
Entity NameAdvocate Health And Hospitals Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700824455
PECOS PAC ID: 7810800935
Enrollment ID: O20031106000064

News Archive

Valproic acid can enhance neuronal regeneration following brachial plexus root avulsion

Brachial plexus root avulsion is the most serious type of peripheral nerve injury. Valproic acid has been shown to exert neuroprotective effects and promote neurite outgrowth in several peripheral nerve injury models. However, whether valproic acid can exert its beneficial effect on neurons after brachial plexus avulsion injury is currently unknown.

Scientists explore ways to personalise radiotherapy dose given to lung cancer patients

Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients - potentially offering improved local control and survival.

Concussion symptoms can be reversed by magnetic stimulation

Concussion symptoms-such as loss of balance, hazy comprehension, sleep disturbance and ability to walk straight-can be reversed by a new type of magnetic stimulation, research at the University of Saskatchewan shows.

Mexican-American children who adapt American culture face Type 2 diabetes risk

Mexican-American children who show evidence of greater adaptation into American culture face significantly higher odds of being at high risk for Type 2 diabetes than those who do not similarly adapt, according to a University of North Texas Health Science Center study.

Allergan's investigational medication rapastinel granted FDA Breakthrough Therapy designation

Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).

Read more Medical News

› Verified 5 days ago

Entity NameNorthshore University Healthsystem Faculty Practice Associates
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1497701882
PECOS PAC ID: 2163334699
Enrollment ID: O20040524000118

News Archive

Valproic acid can enhance neuronal regeneration following brachial plexus root avulsion

Brachial plexus root avulsion is the most serious type of peripheral nerve injury. Valproic acid has been shown to exert neuroprotective effects and promote neurite outgrowth in several peripheral nerve injury models. However, whether valproic acid can exert its beneficial effect on neurons after brachial plexus avulsion injury is currently unknown.

Scientists explore ways to personalise radiotherapy dose given to lung cancer patients

Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients - potentially offering improved local control and survival.

Concussion symptoms can be reversed by magnetic stimulation

Concussion symptoms-such as loss of balance, hazy comprehension, sleep disturbance and ability to walk straight-can be reversed by a new type of magnetic stimulation, research at the University of Saskatchewan shows.

Mexican-American children who adapt American culture face Type 2 diabetes risk

Mexican-American children who show evidence of greater adaptation into American culture face significantly higher odds of being at high risk for Type 2 diabetes than those who do not similarly adapt, according to a University of North Texas Health Science Center study.

Allergan's investigational medication rapastinel granted FDA Breakthrough Therapy designation

Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Hina Siddiqui is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Hina Siddiqui, DO
1860 Paysphere Cir,
Chicago, IL 60674-3328

Ph: (630) 469-9200
Dr Hina Siddiqui, DO
3755 E Main St Ste 190,
St Charles, IL 60174-2463

Ph: (630) 348-3100

News Archive

Valproic acid can enhance neuronal regeneration following brachial plexus root avulsion

Brachial plexus root avulsion is the most serious type of peripheral nerve injury. Valproic acid has been shown to exert neuroprotective effects and promote neurite outgrowth in several peripheral nerve injury models. However, whether valproic acid can exert its beneficial effect on neurons after brachial plexus avulsion injury is currently unknown.

Scientists explore ways to personalise radiotherapy dose given to lung cancer patients

Manchester scientists are working out how to safely increase the radiotherapy dose given to lung cancer patients - potentially offering improved local control and survival.

Concussion symptoms can be reversed by magnetic stimulation

Concussion symptoms-such as loss of balance, hazy comprehension, sleep disturbance and ability to walk straight-can be reversed by a new type of magnetic stimulation, research at the University of Saskatchewan shows.

Mexican-American children who adapt American culture face Type 2 diabetes risk

Mexican-American children who show evidence of greater adaptation into American culture face significantly higher odds of being at high risk for Type 2 diabetes than those who do not similarly adapt, according to a University of North Texas Health Science Center study.

Allergan's investigational medication rapastinel granted FDA Breakthrough Therapy designation

Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).

Read more News

› Verified 5 days ago


Hospitalist Doctors in St Charles, IL


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.